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Letters to the Editor 
Stability of Psychiatric Diagnosis 
Sir, 
I read with great interest the article "Sta-
bility of psychiatric diagnosis (R. Ray and J. 
Roy Chowdhury, Indian Journal of Psychia-
try, 26(2): 164-168, 1984). I have some 
doubts regarding the above article in which 
the total number of patients in Table 1,2 & 3 
does not tally with the description of total 
sample. Also, the exact percentages in Table 2 
and 3 should be corrected and given. 
P.B. BEHERE, 
KAMLESH TIWARI, 
Dept. of Psychiatry, 
Institute of Medical Sciences, 
Banaras Hindu University, 
Varanasi-221005. 
Reply: 
Following are my comments regarding 
the points raised by Dr. P. S. Behere and Ti-
wari: 
Information on all the variables in all 
the patients' charts selected in the study are 
not available, hence the total does not tally. 
Precise precentage distribution in Table 2 
should be like this: Unstable group re-
admission 1 : 39 (47.5%), 2 : 21 (25.6%), 
2 + :22 (26.8%). Precise percentage distri-
bution in Table 3 should be like this: 
Nil: 33 (39.7 %), 1:31 (37.3 %), 2 :9(10.8 %), 
2+ : 10 (12%). The error in calculating the 
percentages is unintentional and regretted. 
RAJAT RAY, 
NIMHANS, Bangalore. 
Does Carbamazepine Alter the 
Electro-Convulsive Threshold ? 
Sir, 
The use of Carbamazepine has in-
creased greatly over the past few years, 
especially in the management of episodic 
psychoses resistant to other therapies. We 
would like to bring to the notice of readers, 
the possible influence of carbamazepine on 
electro-convulsive threshold. 
A thirty year old female suffering from 
schizoaffective illness of 10 years duration 
and major epilepsy of 6 years duration was 
admitted to our wards. Her epilepsy was 
well controlled with 60 mgm Phenobarbi-
tone OD but she was suffering frequent re-
lapses of psychosis. Carbamazepine (200 
mg BD and 400 mg HS) and Lithium (600 
mg t.i.d. with a serum level of 1.0 m Eq/L) 
was instituted for therapeutic and mainten-
ance purposes after Lithium alone or with 
antipsychotics had failed over the past few 
years. Two weeks trial of this combination 
having produced no results, we decided to 
add electro-convulsive therapy. In her pre-
vious episodes she had shown moderate re-
sponse to ECT at less than 120 V and 0.8s 
electrical stimuli. However, during the pres-
ent course, she failed to obtain convulsions 
even at 150 V and 1.0s duration stimuli gi-
ven repeatedly (Direct ECT). Empirically it 
was decided to alter the dosage regimen of 
Carbamazepine to 400 mg morning and af-
ternoon, avoiding a dose on the night prior 
to the ECT. With this she obtained convul-
sions with ECT. To confirm this ob-
servation an A-B-A-B design was executed 
in this patient as well as in two others (who 
were on similar treatment, i.e., ECT with 
Carbamazepine) and we consistently found 174  LETTERS TO THE EDITOR 
that a reduction or withdrawal of Carbama-
zepine on the night before ECT produced 
satisfactory convulsions whereas continua-
tion of the drug, as usual, hampered induc-
tion of seizures or raised the required vol-
tage and duration of stimuli. No changes 
were made in any other treatment modali-
ties which the patients were receiving, dur-
ing this trial. 
These observations indicate that carba-
mazepine may be interfering with seizure 
threshold and hence with the therapeutic 
induction of seizures. In our experience a si-
milar phenomenon has neither been no-
ticed with other anticonvulsants when used 
with ECT for epilepsy associated psy-
choses, nor is a similar observation reported 
in literature. Majkowski (1983) has shown 
an increase in current intensity required for 
after discharge and for producing seizures 
in ferrets on Carbamazepine. However, 
Okuma (1983) reports no significant 
change in seizure threshold by this drug in 
animals. It is likely, though speculative, that 
the combined GABAergic effect of Carba-
mazepine (Okuma, 1983) and ECT (Sa-
ckeim et al, 1983) may be responsible for 
our observation. Interestingly, contrary to 
reports of Choudhary et al., (1983) and 
Shukla et al., (1984), none of our patients 
had any neurotoxic complications due to 
the above combination therapy. 
Systematic research in this area may 
throw more light on the explanatory me-
chanism ol this phenomenon and on the 
mode of action or Carbamazepine. 
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History of Mental Hospital In India 
Dear Prof. Shridhar Sharma, 
I have received comments from many 
psychiatrists regarding your article entitled 
"History of Mental Hospitals in Indian Sub-
Continent", IJP, 1984 Vol. 26, No. 4, 295-
300. I am enclosing herewith a copy of 
some of the letters to you. There are com-
ments that there are factual errors. Since it 
is an important issue, I would like you to 
kindly clarify these observations. 
S. M. CHANNABASAVANNA 
Hon. Editor, 
Indian Journal of Psychiatry. 
Reply: 
Dear Editor, 
I have carefully gone through the con-
tents of letters sent by you. 